全球有超过 5000 万痴呆症患者,神经退行性疾病因其发病率不断上升且缺乏有效疗法而备受关注。本报告依托 CAS Content Collection™,为您提供了一份了解新兴趋势、新机遇及未来挑战的路线图。深入探索潜在生物标志物、针对蛋白质错误折叠的机遇、临床研发管线以及前景广阔的治疗方法。
Is your R&D data ready for the future? The CAS Intelligence Hub is a powerful integrated solution that transforms fragmented scientific R&D data into a harmonized, AI-ready knowledge environment.